Breast Cancer: Chemo-Resistance

Some cancers are difficult to treat and aggressive including the "triple-negative" breast cancer. This type of cancer is chemoresistant even before chemotherapy begins. Here are the latest discoveries chemo-resistance in breast cancer.

July 4, 2020

New Insights in Gene Expression Alteration as Effect of Paclitaxel Drug Resistance in Triple Negative Breast Cancer Cells

Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology
Ancuta JurjCornelia Braicu
July 1, 2020

Call for assessing treatment-induced gonadotoxicity of platinum-based chemotherapy in early breast cancer

Breast Cancer Research and Treatment
Marta PerachinoMatteo Lambertini
June 27, 2020

Perturbations of pathway co-expression network identify a core network in metastatic breast cancer

Computational Biology and Chemistry
Claudia CavaIsabella Castiglioni
July 1, 2020

Effects of chitosan-loaded hydroxyapatite on osteoblasts and osteosarcoma for chemopreventative applications

Materials Science & Engineering. C, Materials for Biological Applications
Caitlin KoskiSusmita Bose
June 28, 2020
Open Access

Incidence of pneumonitis/interstitial lung disease induced by HER2-targeting therapy for HER2-positive metastatic breast cancer

Breast Cancer Research and Treatment
Michelle D HackshawCharles A Powell
July 2, 2020
Open Access

Characterization of Triple-Negative Breast Cancer MDA-MB-231 Cell Spheroid Model

OncoTargets and Therapy
Zhaoming HuangJianhui Tang
July 7, 2020

Clinical decision trees support systematic evaluation of multidisciplinary team recommendations

Breast Cancer Research and Treatment
Mathijs P HendriksAgnes Jager
July 1, 2020

M2 macrophage-derived exosomes facilitate hepatocarcinoma metastasis by transferring αM β2 integrin to tumor cells

Hepatology : Official Journal of the American Association for the Study of Liver Diseases
Jindao WuXuehao Wang
June 26, 2020
Open Access

Characterization of T-DM1-resistant breast cancer cells

Pharmacology Research & Perspectives
Juliette SauveurCharles Dumontet
July 2, 2020
Open Access

Predictors of Neoadjuvant Chemotherapy Response in Breast Cancer: A Review

OncoTargets and Therapy
Weilin XuJinhai Tang
July 1, 2020

A case for Tamoxifen with ovarian function suppression

Breast Cancer Research and Treatment
Pallavi Kopparthy, Karen Daily
July 6, 2020

Tumor-infiltrating lymphocytes (TILs) in ER+/HER2- breast cancer

Breast Cancer Research and Treatment
C CriscitielloG Curigliano
July 1, 2020

The Role of Neoadjuvant Therapy in Melanoma

Current Oncology Reports
Zahra R KellyDiwakar Davar

Sign up to follow this feed and discover related papers.

Related Feeds

Angiogenesis Inhibitors to Treat Cancer

Cancer treatments including angiogenesis inhibitors prevent tumor cells from receiving nutrients and oxygen. Here is the latest research on angiogenesis inhibitors for the treatment of cancer.

Biosensors for Cancer Detection

Biosensors are devices that are designed to detect a specific biological analyte by essentially converting a biological entity (ie, protein, DNA, RNA) into an electrical signal that can be detected and analyzed. The use of biosensors in cancer detection and monitoring holds vast potential. Biosensors can be designed to detect emerging cancer biomarkers and to determine drug effectiveness at various target sites. Biosensor technology has the potential to provide fast and accurate detection, reliable imaging of cancer cells, and monitoring of angiogenesis and cancer metastasis, and the ability to determine the effectiveness of anticancer chemotherapy agents.

Breast Cancer Triple-N

Breast cancer cells have receptors for estrogen, progesterone, HER2 receptors (also called ERBB2). Triple-negative breast cancers do not have any of these receptors. Here are the latest discoveries pertaining to triple-negative breast cancers.

Breast Cancer: BRCA1 & BRCA2

Mutations involving BRCA1, found on chromosome 17, and BRCA2, found on chromosome 13, increase the risk for specific cancers, such as breast cancer. Discover the last research on breast cancer BRCA1 and BRCA2 here.

Breast Cancer: Risk Factors

Breast cancer is a multifactorial disease that is influenced by both environmental and genetic factors. Discover the latest research on the environmental and genetic risk factors for breast cancer here.

Breast Cancer: Therapeutic Approaches

Several different therapeutic approaches are used to treat breast cancer. These include chemotherapy, hormonal therapy, targeted therapy, and Immunotherapy. Discover the latest research on breast cancer therapeutic approaches here.

Breast Invasive Carcinoma

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

Breast Tumorigenesis

Breast tumorigenesis involves the production or formation of tumor(s) in breast tissue. Discover the latest research on breast tumorigenesis here.

CAR-T cells

Chimeric antigen receptor (CAR) T cells are cells that are genetically engineered to recognize and target specific proteins. The ability of these cells to recognize cancer antigens and eliminate tumor cells have transformed cancer immunotherapy approaches. Here is the latest research on CAR-T cells.

Cancer Cell Invasion: Nanomedicine

Nanomedicine is a promising alternative for cancer detection and therapy that utilizes nanoparticles, such as liposomes. Nanoparticles can potentially target cancer cell invasion and metastasis. Discover the latest research on Cancer Cell Invasion: Nanomedicine here.

© 2020 Meta ULC. All rights reserved